Literature DB >> 2112814

The effects of antithyroid drugs on intercellular mediators.

R Wilson1, J H McKillop, M Travers, J Smith, E Smith, J A Thomson.   

Abstract

The antithyroid drugs methimazole and propylthiouracil have been shown to affect the function of monocytes and B and T lymphocytes in vitro. The aim of this study was to investigate the mechanism responsible for signalling between these various cell types. Propranolol, a drug known to have no effect on the immune system, was also included as a control against which the effects of the other drugs could be monitored. Peripheral blood lymphocytes from control subjects were stimulated with phytohemagglutinin in the presence or absence of antithyroid drugs. Propranolol was found significantly to inhibit beta 2 microglobulin production. In addition it was also found to be a very weak scavenger of free oxygen radicals. Methimazole significantly increased interleukin 2 levels (p less than 0.01), but had no significant effect on either gamma-interferon or beta 2 microglobulin production. Propylthiouracil also increased interleukin 2 levels (p less than 0.001) and significantly decreased beta 2 microglobulin production (p less than 0.01). Both drugs were found to be scavengers of free O2 radicals. It would appear that IL-2 is involved in intercellular signalling and this process may involve free radicals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2112814     DOI: 10.1530/acta.0.1220605

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  2 in total

1.  Atom level electrotopological state indexes in QSAR: designing and testing antithyroid agents.

Authors:  R R Abou-Shaaban; H A al-Khamees; H S Abou-Auda; A P Simonelli
Journal:  Pharm Res       Date:  1996-01       Impact factor: 4.200

2.  The influence of thyroxine and propyl thiouracil on Parastrongylus malaysiensis infection in rats.

Authors:  A B Kamis; R A Ahmad; J S Chang; S Ambu
Journal:  Parasitol Res       Date:  1994       Impact factor: 2.289

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.